Administrator Info
Name: Elizabeth James
Phone: 612-624-9996
Fax: 612-625-4410
Email: [email protected]
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455
After graduating from Damascus University, Faculty of Medicine in 1998, Dr. Obeid completed his Internal Medicine training in 2003 and Infectious Diseases training in 2007 at Henry Ford Hospital, Detroit, Michigan. Dr. Obeid practiced Internal Medicine at William Beaumont Hospital and Infectious Diseases at St. John Hospital and Medical Center where he attended on inpatient consultation rounds and supervised Infectious Diseases fellows, Internal Medicine residents, and medical students. He also was an Assistant Professor at Wayne State University in Detroit, Michigan. Dr. Obeid served as the consultant of latent and active TB cases for the Macomb County Health Department in Michigan. His research activities focused on infections in immunocompromised patients, which lead Dr. Obeid to pursue a one year special Fellowship training in the field of Transplant Infectious Diseases at the Cleveland Clinic Foundation. After his graduation from this special training in 2014 he joined the Infectious Diseases Division at the University of Minnesota as an Assistant Professor. Dr. Obeid's research interests are focused on therapies and outcomes in immunocompromised patients especially solid organ and bone marrow transplant recipients.
MD, University of Damascus
Kaplan A, Young JH, Kandaswamy R, Berglund D, Knoll BM, Sieger G, Cavert W, Matas A, Obeid KM. Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients. Can J Infect Dis Med Microbiol. 2020 Oct 9;2020:8883183. doi: 10.1155/2020/8883183. PMID: 33101558; PMCID: PMC7569440.,
Obeid KM, Aguilar J, Szpunar S, Sharma M, del Buston R, Al-Katib A, Johnson LB. Risk factors for Pneumocystis jirovecii Pneumonia (PCP) in patients with lymphoproliferative disorders. Clin Lymphoma, Myeloma, and Leukemia: 12: 66-9, 2012.,
Obeid, K. M., Sapkota, S., Cao, Q., Richmond, S., Watson, A. P., Karadag, F. K., Young, J. H., Pruett, T., Weisdorf, D. J., Ustun, C. (2021). Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients. Transplant Infectious Disease, 24(1), e13720. PMID: 34455662 doi: 10.1111/tid.13720,
Blumberg, E. A., Collins, G., Young, J. H., Nguyen, M. H., Michonneau, D., Temesgen, Z., Origȕen, J., Barcan, L., Obeid, K. M., Belloso, W. H., Gras, J., Corbelli, G. M., Neaton, J. D., Lundgren, J., Snydman, D. R., Molina, J. M. (2021). Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study. Transplant Infectious Disease, 24(1), e13770. PMID: 34821423 doi: 10.1111/tid.13770,
Nair, S. N., Bhaskaran, A., Chandorkar, A., Fontana, L., Obeid, K. M. (2022). Noroviral diarrhea in solid organ transplant recipients: An analysis of interventions and outcomes. Clinical Transplantation, e14855. PMID: 36374209 doi: 10.1111/ctr.14855,
Clinical research and research related to outcomes in immuno-compromised patients
American College of Physicians, Member
Infectious Diseases Society of America, Member
Michigan Infectious Diseases Society, Member
American Society of Transplantation, Member
Solid Organ Transplant; Infectious Disease; Nosocomial Infections; Infections in Immunocompromised patients; Bone Marrow Transplant Infectious Diseases; Fever of Unknown Origin